ANCC PMHNP CERTIFICATION EXAM STUDY GUIDE 2026/2027 -
COMPLETE PSYCHIATRIC MENTAL HEALTH NURSE
PRACTITIONER REVIEW WITH PRACTICE QUESTIONS &
ANSWERS
230 Questions with Answers and Detailed Rationales
100 PERCENT GUARANTEED PASS
INSTANT DOWNLOAD ANSWERS INCLUDED
IMPORTANCE OF THIS DOCUMENT
This comprehensive examination preparation guide has been meticulously developed to help you succeed in the
ANCC PMHNP CERTIFICATION EXAM STUDY GUIDE 2026/2027 - COMPLETE PSYCHIATRIC MENTAL
HEALTH NURSE PRACTITIONER REVIEW WITH PRACTICE QUESTIONS & ANSWERS. It contains 230
carefully selected questions that reflect the most current exam content and testing strategies. Each question is
accompanied by a correct answer and a detailed rationale that explains the underlying pathophysiology,
pharmacology, or clinical reasoning.
Self-Assessment – Test your knowledge and Exam Preparation – Familiarize yourself with the
identify areas requiring further question format and content
study areas
Concept Reinforcement – Deepen your Confidence Building – Develop test-taking
understanding through strategies and reduce
evidence-based exam anxiety
rationales
Time Management – Practice answering
questions under simulated
exam conditions
Review Summary 230 Questions
Foundations - Application - ANCC Pmhnp Certification Study Guide 2026/2027 Complete Psychiatric
Mental Health Nurse Practitioner Review WITH & Psychiatric Mental Health Nurse Practitioner Pmhnp
Certification Graduate
All answers with rationales
,Table of Contents
Content Area Questions Key Topics
ANCC Pmhnp Certification 1-39 Disorder, Treatment-resistant, Appropriate, Depression, Evidence
Study Guide 2026/2027
Complete Psychiatric Mental
Health Nurse Practitioner
Review WITH & Psychiatric
Mental Health Nurse
Practitioner Pmhnp
Certification Graduate
Schizophrenia 40-78 Disorder, Appropriate, Likely, Strategy, Pmhnp
Appropriate 79-117 Disorder, Medication, Major Depressive, Responded, Evidence
Treatment-resistant 118-156 Disorder, Schizophrenia, Bipolar, Treatment, Symptoms
Bipolar 157-195 Disorder, Evidence, Appropriate, Therapy, Ssris
Depression 196-230 Disorder, Pmhnp, Considered, Bipolar, Anxiety
TOTAL 230 All questions include answers and detailed rationales
,Section A - ANCC Pmhnp Certification Study Guide
2026/2027 Complete Psychiatric Mental Health Nurse
Practitioner Review WITH & Psychiatric Mental Health Nurse
Practitioner Pmhnp Certification Graduate
Q1.
A patient with treatment-resistant depression has failed two adequate SSRI trials. Which
augmentation strategy is most supported by evidence for rapid onset of action?
A. Adding aripiprazole B. Adding quetiapine
C. Adding lithium D. Adding thyroid hormone (T3)
Correct: B - Adding quetiapine
Rationale:Quetiapine has demonstrated rapid antidepressant effects in augmentation trials,
with onset often within 1 week. Aripiprazole and lithium also have evidence but slower onset.
T3 augmentation is more traditional but not as rapid.
Q2.
Which psychotherapeutic approach is most appropriate for a patient with borderline
personality disorder who frequently engages in self-harm during sessions and reports
chronic emptiness?
A. Classical psychoanalysis B. Dialectical behavior therapy (DBT)
C. Cognitive behavioral therapy (CBT) D. Supportive therapy
without modification
Correct: B - Dialectical behavior therapy (DBT)
Rationale:DBT is specifically designed for BPD, targeting emotional dysregulation and
self-harm through skills training and validation. Psychoanalysis may be contraindicated due to
regression. CBT requires adaptation; supportive therapy lacks structure.
Q3.
A patient on fluoxetine 60 mg/day for 8 weeks has partial response. Which
pharmacogenomic finding would most likely explain poor metabolism and increased side
effects?
A. CYP2D6 ultrarapid metabolizer B. CYP2C19 poor metabolizer phenotype
phenotype
C. CYP2D6 poor metabolizer phenotype D. CYP3A4 inducer phenotype
Page 3
, Section A - ANCC Pmhnp Certification Study Guide 2026/2027 Complete Psychiatric Mental Health Nurse Practitioner Review WITH &
Psychiatric Mental Health Nurse Practitioner Pmhnp Certification Graduate
Correct: C - CYP2D6 poor metabolizer phenotype
Rationale:Fluoxetine is a substrate of CYP2D6; poor metabolizers have higher plasma levels
and more side effects. CYP2C19 is less relevant. Ultrarapid metabolizers would have lower
levels, not higher.
Q4.
Which medication is most likely to cause corrected QT interval prolongation and requires
baseline and follow-up ECG monitoring?
A. Sertraline B. Citalopram
C. Bupropion D. Mirtazapine
Correct: B - Citalopram
Rationale:Citalopram has a dose-dependent risk of QT prolongation, with FDA warnings
recommending ECG monitoring. Sertraline, bupropion, and mirtazapine have lower risk.
Q5.
A patient with schizophrenia has persistent negative symptoms despite adequate
antipsychotic therapy. Which agent has the strongest evidence for improving negative
symptoms?
A. Haloperidol B. Olanzapine
C. Cariprazine D. Risperidone
Correct: C - Cariprazine
Rationale:Cariprazine has shown significant efficacy for negative symptoms in trials.
Olanzapine and risperidone are atypical but less specific. Haloperidol is primarily positive
symptoms.
Q6.
Which of the following is a core feature differentiating delirium from dementia in an
acutely confused patient?
A. Gradual onset and progressive decline B. Fluctuating level of consciousness with
acute onset
C. Preserved attention and focus D. Irreversible cognitive impairment
Correct: B - Fluctuating level of consciousness with acute onset
Page 4
COMPLETE PSYCHIATRIC MENTAL HEALTH NURSE
PRACTITIONER REVIEW WITH PRACTICE QUESTIONS &
ANSWERS
230 Questions with Answers and Detailed Rationales
100 PERCENT GUARANTEED PASS
INSTANT DOWNLOAD ANSWERS INCLUDED
IMPORTANCE OF THIS DOCUMENT
This comprehensive examination preparation guide has been meticulously developed to help you succeed in the
ANCC PMHNP CERTIFICATION EXAM STUDY GUIDE 2026/2027 - COMPLETE PSYCHIATRIC MENTAL
HEALTH NURSE PRACTITIONER REVIEW WITH PRACTICE QUESTIONS & ANSWERS. It contains 230
carefully selected questions that reflect the most current exam content and testing strategies. Each question is
accompanied by a correct answer and a detailed rationale that explains the underlying pathophysiology,
pharmacology, or clinical reasoning.
Self-Assessment – Test your knowledge and Exam Preparation – Familiarize yourself with the
identify areas requiring further question format and content
study areas
Concept Reinforcement – Deepen your Confidence Building – Develop test-taking
understanding through strategies and reduce
evidence-based exam anxiety
rationales
Time Management – Practice answering
questions under simulated
exam conditions
Review Summary 230 Questions
Foundations - Application - ANCC Pmhnp Certification Study Guide 2026/2027 Complete Psychiatric
Mental Health Nurse Practitioner Review WITH & Psychiatric Mental Health Nurse Practitioner Pmhnp
Certification Graduate
All answers with rationales
,Table of Contents
Content Area Questions Key Topics
ANCC Pmhnp Certification 1-39 Disorder, Treatment-resistant, Appropriate, Depression, Evidence
Study Guide 2026/2027
Complete Psychiatric Mental
Health Nurse Practitioner
Review WITH & Psychiatric
Mental Health Nurse
Practitioner Pmhnp
Certification Graduate
Schizophrenia 40-78 Disorder, Appropriate, Likely, Strategy, Pmhnp
Appropriate 79-117 Disorder, Medication, Major Depressive, Responded, Evidence
Treatment-resistant 118-156 Disorder, Schizophrenia, Bipolar, Treatment, Symptoms
Bipolar 157-195 Disorder, Evidence, Appropriate, Therapy, Ssris
Depression 196-230 Disorder, Pmhnp, Considered, Bipolar, Anxiety
TOTAL 230 All questions include answers and detailed rationales
,Section A - ANCC Pmhnp Certification Study Guide
2026/2027 Complete Psychiatric Mental Health Nurse
Practitioner Review WITH & Psychiatric Mental Health Nurse
Practitioner Pmhnp Certification Graduate
Q1.
A patient with treatment-resistant depression has failed two adequate SSRI trials. Which
augmentation strategy is most supported by evidence for rapid onset of action?
A. Adding aripiprazole B. Adding quetiapine
C. Adding lithium D. Adding thyroid hormone (T3)
Correct: B - Adding quetiapine
Rationale:Quetiapine has demonstrated rapid antidepressant effects in augmentation trials,
with onset often within 1 week. Aripiprazole and lithium also have evidence but slower onset.
T3 augmentation is more traditional but not as rapid.
Q2.
Which psychotherapeutic approach is most appropriate for a patient with borderline
personality disorder who frequently engages in self-harm during sessions and reports
chronic emptiness?
A. Classical psychoanalysis B. Dialectical behavior therapy (DBT)
C. Cognitive behavioral therapy (CBT) D. Supportive therapy
without modification
Correct: B - Dialectical behavior therapy (DBT)
Rationale:DBT is specifically designed for BPD, targeting emotional dysregulation and
self-harm through skills training and validation. Psychoanalysis may be contraindicated due to
regression. CBT requires adaptation; supportive therapy lacks structure.
Q3.
A patient on fluoxetine 60 mg/day for 8 weeks has partial response. Which
pharmacogenomic finding would most likely explain poor metabolism and increased side
effects?
A. CYP2D6 ultrarapid metabolizer B. CYP2C19 poor metabolizer phenotype
phenotype
C. CYP2D6 poor metabolizer phenotype D. CYP3A4 inducer phenotype
Page 3
, Section A - ANCC Pmhnp Certification Study Guide 2026/2027 Complete Psychiatric Mental Health Nurse Practitioner Review WITH &
Psychiatric Mental Health Nurse Practitioner Pmhnp Certification Graduate
Correct: C - CYP2D6 poor metabolizer phenotype
Rationale:Fluoxetine is a substrate of CYP2D6; poor metabolizers have higher plasma levels
and more side effects. CYP2C19 is less relevant. Ultrarapid metabolizers would have lower
levels, not higher.
Q4.
Which medication is most likely to cause corrected QT interval prolongation and requires
baseline and follow-up ECG monitoring?
A. Sertraline B. Citalopram
C. Bupropion D. Mirtazapine
Correct: B - Citalopram
Rationale:Citalopram has a dose-dependent risk of QT prolongation, with FDA warnings
recommending ECG monitoring. Sertraline, bupropion, and mirtazapine have lower risk.
Q5.
A patient with schizophrenia has persistent negative symptoms despite adequate
antipsychotic therapy. Which agent has the strongest evidence for improving negative
symptoms?
A. Haloperidol B. Olanzapine
C. Cariprazine D. Risperidone
Correct: C - Cariprazine
Rationale:Cariprazine has shown significant efficacy for negative symptoms in trials.
Olanzapine and risperidone are atypical but less specific. Haloperidol is primarily positive
symptoms.
Q6.
Which of the following is a core feature differentiating delirium from dementia in an
acutely confused patient?
A. Gradual onset and progressive decline B. Fluctuating level of consciousness with
acute onset
C. Preserved attention and focus D. Irreversible cognitive impairment
Correct: B - Fluctuating level of consciousness with acute onset
Page 4
